Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Get Free Report) was the target of a significant decrease in short interest in December. As of December 31st, there was short interest totaling 2,161 shares, a decrease of 33.7% from the December 15th total of 3,261 shares. Based on an average daily trading volume, of 341 shares, the days-to-cover ratio is currently 6.3 days. Based on an average daily trading volume, of 341 shares, the days-to-cover ratio is currently 6.3 days.
Oaktree Acquisition Corp. III Life Sciences Stock Down 1.5%
Shares of OACCU stock traded down $0.17 during trading hours on Friday, reaching $10.64. 254 shares of the company traded hands, compared to its average volume of 4,151. The firm has a 50-day moving average price of $10.76 and a 200 day moving average price of $10.74. Oaktree Acquisition Corp. III Life Sciences has a 12-month low of $10.12 and a 12-month high of $11.06.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Oaktree Acquisition Corp. III Life Sciences stock. Clear Street Group Inc. bought a new position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 20,333 shares of the company’s stock, valued at approximately $217,000.
Oaktree Acquisition Corp. III Life Sciences Company Profile
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCU) is a special purpose acquisition company formed to target businesses in the life sciences sector. As a blank‐check vehicle, the company raises capital through an initial public offering with the purpose of acquiring or merging with one or more operating companies. Its focus areas include biotechnology, pharmaceuticals, medical devices and healthcare services.
Established in Delaware and sponsored by affiliates of Oaktree Capital Management, OACCU leverages the resources and investment expertise of one of the world’s leading alternative asset managers.
Featured Stories
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
